Roggwil, February 2, 2021 – In October 2020, work began on a new packaging for the tinniwell. This became necessary because the old model was too time-consuming to equip due to the increased sales figures. The new packaging is much more stable than the previous version and our product is presented to the customer in a much more valuable way. After opening the packaging, the patient is presented with the tinnitus therapy device including its accessories “at a glance”. Due to its new design, the packaging can now also be used internationally, and no country-specific packaging has to be produced. Delivery in the new design will begin in March 2021.
++ About Resaphene Suisse AG
Resaphene Suisse AG, based in Roggwil, Switzerland, is a medical technology company that was founded in 2015 and has been selling a tinnitus therapy device under the name tinniwell since 2016. Resaphene Deutschland GmbH in Constance, Resaphene UK Ltd. act as further sales companies in London and Resaphene US LLC in the US.
++ Contact for questions:
Resaphene Suisse AG
Mrs. Anke Rauterkus (Chief Executive Officer)
T. +41 714500668